The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kay Mark A since 2021.
This trader's CIK number is 1752537.
At the time of last reporting, Kay Mark A was the Director of Logicbio Therapeutics, Inc.. (stock ticker symbol LOGC).
Also see all insider trading activities at Logicbio Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | LOGC | 0 | $0 | 0 | $0 | 2,199 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-01-01 | LOGC | Option Ex | 2,199 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kay Mark A (Director of Logicbio Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.